Revolution Medicines (RVMD) Intangibles (2019 - 2026)
Revolution Medicines (RVMD) reported Intangibles of $55.8 million for Q2 2026, down 0.6% from $56.14 million a year earlier and unchanged from the prior quarter.
Revolution Medicines (RVMD) Intangibles (2019 - 2026) Analysis & Trends
Dating back to Q4 2019, Revolution Medicines' Intangibles record includes 27 quarters.
- Intangibles has declined for six consecutive years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- By year, Intangibles came in at $56.67 million in FY2024 (-1.9%), $57.74 million in FY2023 (-1.8%), $58.81 million in FY2022 (-1.8%) and $59.88 million in FY2021 (-1.8%).
- Five-year quarterly Intangibles spans a low of $55.8 million in Q4 2025 and a high of $60.14 million in Q3 2021.
- Year over year, Intangibles has now declined in each of the last 23 quarters, with an average decline of 1.6% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 0.6% (Q2 2026) and 2.7% (Q3 2022) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $55.8 million (Q1 2026), $55.8 million (Q4 2025) and $55.87 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 55.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.80 Mn |
| Mar 31, 2026 | 55.80 Mn |
| Dec 31, 2025 | 55.80 Mn |
| Sep 30, 2025 | 55.87 Mn |
| Jun 30, 2025 | 56.14 Mn |
| Mar 31, 2025 | 56.40 Mn |
| Dec 31, 2024 | 56.67 Mn |
| Sep 30, 2024 | 56.94 Mn |
| Jun 30, 2024 | 57.21 Mn |
| Mar 31, 2024 | 57.47 Mn |
| Dec 31, 2023 | 57.74 Mn |
| Sep 30, 2023 | 58.01 Mn |
| Jun 30, 2023 | 58.27 Mn |
| Mar 31, 2023 | 58.54 Mn |
| Dec 31, 2022 | 58.81 Mn |
| Sep 30, 2022 | 58.54 Mn |
| Jun 30, 2022 | 59.34 Mn |
| Mar 31, 2022 | 59.61 Mn |
| Dec 31, 2021 | 59.88 Mn |
| Sep 30, 2021 | 60.14 Mn |
Revolution Medicines Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=RVMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();